Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. NuVasive takes a shellacking on lowered guidance
Shares of NuVasive are down more than 30% today after the medical device company lowered its outlook for the rest of the year.
6. Medtronic closes 1st phase of Symplicity renal denervation feasibility trial
Medtronic said the 1st phase of a small trial of the next iteration of its Symplicity device for treating high blood pressure showed a 100% success rate.
5. FDA warns Zimmer on hip implant manufacturing
Orthopedic medical device maker Zimmer received an FDA warning for hip implants at a Puerto Rico manufacturing facility.
4. Allergan back-tracks on Lap-Band for obese teens
Allergan retracts efforts to win FDA approval to market its Lap-Band bariatric surgery to teenagers.
3. Medical device cybersecurity a “high priority” for Medtronic, says CEO
Medtronic is taking steps to address concerns about medical device hacking and cybersecurity, CEO Omar Ishrak tells MassDevice.com.
2. FDA approves Boston Scientific’s market-first wire-free pacemaker
Medical device titan Boston Scientific lands FDA approval for the subcutaneous lead-free heart rhythm implant it acquired in the $1.35 billion deal for Cameron Health.
1. Stryker appoints Lobo CEO, CFO Hartman prepares to leave
Stryker shakes up its corporate deck, announcing the appointment of Kevin Lobo as its new president & CEO, the resignation of interim CEO and chief financial officer Curt Hartman, and appointing Dean Bergy its interim CFO, all of which took effect October 1.
